![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, September 22, 2020 2:49:19 AM
What I do know from the pharma investment world is that drug development from the pre-clinical stage is a long way from home.
Need to test efficacy in Murine (mouse) model, then a double-blind study (gold standard) in humans at some point.
Submission of testing protocols, methods, endpoints, dosing levels, ethical standards, etc.
All the while monitoring safety and effectiveness.
Many years and many millions of dollars.
Could be many years before FDA approval.
So.. where does it leave us?
Maybe PAOG is busy talking to the sister about how they merge?
Is it Oxi-Thyme?
LS5
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM